CERVELLO, MELCHIORRE
CERVELLO, MELCHIORRE
Istituto per la Ricerca e l'Innovazione Biomedica -IRIB
A new extracellular matrix protein of the sea urchin embryo with properties of a substrate adhesion molecule.
1992 Matranga, V; Di Ferro, D; Zito, F; Cervello, M; Nakano, E
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
2016 Augello G.; Puleio R.; Emma M.R.; Cusimano A.; Loria G.R.; McCubrey J.A.; Montalto G.; Cervello M.
Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
2020 Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; BuenoSilva B; Matias de Alencar S; Falasca M; Montalto G; Melchiorre Cervello; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA;
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
2019 Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A.
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
2019 Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja
Adhesion of sea urchin embryonic cells to substrata coated with cell adhesion molecules.
1991 Matranga, V; Di Ferro, D; Cervello, M; Zito, F; Nakano, E
Advances in targeting signal transduction pathways.
2012 McCubrey JA; Steelman LS; Chappell WH; Sun L; Davis NM; Abrams SL; Franklin RA; Cocco L; Evangelisti C; Chiarini F; Martelli AM; Libra M; Candido S; Ligresti G; Malaponte G; Mazzarino MC; Fagone P; Donia M; Nicoletti F; Polesel J; Talamini R; Bäsecke J; Mijatovic S; MaksimovicIvanic D; Michele M; Tafuri A; DuliskaLitewka J; Laidler P; D'Assoro AB; Drobot L; Umezawa D; Montalto G; Cervello M; Demidenko ZN.
Akt as a Therapeutic Target in Cancer.
2008 Steelman, Sl; Stadelman, Km; Chappell, Wh; Horn, S; Bäsecke, J; Cervello, M; Nicoletti, F; Libra, M; Martelli, Am; Mccubrey, Ja
Altered gene expression profiles in liver cancer cells upon sorafenib treatment.
2010 Cervello, M; Bachvarov, D; Cusimano, A; Azzolina, A; Lampiasi, N; Abbaleo, S; Sardina, F; Giannitrapani, L; Mccubrey, Ja; Montalto, G
Altered gene expression profiles in liver cancer cells upon sorafenib treatment.
2011 Cervello, M; Cusimano, A; Bachvarov, D; Azzolina, A; Mccubrey, Ja; Montalto, G; Lampiasi, N
Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells.
2013 A Cusimano; N D'Alessandro; JA McCubrey; G Montalto; M Cervello
Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression
2004 Notarbartolo M; Poma P; Di Peri D; Cervello M; DAlessandro N
Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression.
2004 Notarbartolo, M; Poma, P; Di Peri, D; Cervello, M; Dalessandro, N
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression
2005 Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; DAlessandro N
Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism.
2009 Lampiasi, N; Azzolina, A; D'Alessandro, N; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production
2005 Notarbartolo M; Labbozzetta M; Poma P; Alaimo A; Maurici A; Cervello M; DAlessandro N
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production.
2005 Notarbartolo, M; Labbozzetta, M; Poma, P; Alaimo, A; Maurici, A; Cervello, M; Dalessandro, N
Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production
2006 Poma, P; Notarbartolo, M; Labbozzetta, M; Sanguedolce, R; Alaimo, A; Carina, V; Maurici, A; Cusimano, A; Cervello, M; D'Alessandro, N
Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production
2006 Poma, P; Notarbartolo, M; Labbozzetta, M; Sanguedolce, R; Alaimo, A; Carina, V; Maurici, A; Cusimano, ; Cervello, M; D'Alessandro, N
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells
2005 Cusimano A; Foderà D; Lampiasi N; Azzolina A; Montalto G; Cervello M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new extracellular matrix protein of the sea urchin embryo with properties of a substrate adhesion molecule. | 1-gen-1992 | Matranga, V; Di Ferro, D; Zito, F; Cervello, M; Nakano, E | |
| A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells | 1-gen-2016 | Augello G.; Puleio R.; Emma M.R.; Cusimano A.; Loria G.R.; McCubrey J.A.; Montalto G.; Cervello M. | |
| Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | 1-gen-2020 | Akula SM; Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Cocco L; Ramazzotti G; Ratti S; Follo MY; Martelli AM; Murata RM; Rosalen PL; BuenoSilva B; Matias de Alencar S; Falasca M; Montalto G; Melchiorre Cervello; Notarbartolo M; Gizak A; Rakus D; Libra M; McCubrey JA; | |
| Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Abrams S.L.; Follo M.Y.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ratti S.; Martelli A.M.; Candido S.; Libra M.; Murata R.M.; Rosalen P.L.; Montalto G.; Cervello M.; Gizak A.; Rakus D.; Mao W.; Lombardi P.; McCubrey J.A. | |
| Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells | 1-gen-2019 | Akula, Sm; Candido, S; Libra, M; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Ramazzotti, G; Ratti, S; Follo, My; Martelli, Am; Murata, Rm; Rosalen, Pl; Buenosilva, B; Matias de Alencar, S; Montalto, G; Cervello, M; Gizak, A; Rakus, D; Mao, W; Lin, Hl; Lombardi, P; Mccubrey, Ja | |
| Adhesion of sea urchin embryonic cells to substrata coated with cell adhesion molecules. | 1-gen-1991 | Matranga, V; Di Ferro, D; Cervello, M; Zito, F; Nakano, E | |
| Advances in targeting signal transduction pathways. | 1-gen-2012 | McCubrey JA; Steelman LS; Chappell WH; Sun L; Davis NM; Abrams SL; Franklin RA; Cocco L; Evangelisti C; Chiarini F; Martelli AM; Libra M; Candido S; Ligresti G; Malaponte G; Mazzarino MC; Fagone P; Donia M; Nicoletti F; Polesel J; Talamini R; Bäsecke J; Mijatovic S; MaksimovicIvanic D; Michele M; Tafuri A; DuliskaLitewka J; Laidler P; D'Assoro AB; Drobot L; Umezawa D; Montalto G; Cervello M; Demidenko ZN. | |
| Akt as a Therapeutic Target in Cancer. | 1-gen-2008 | Steelman, Sl; Stadelman, Km; Chappell, Wh; Horn, S; Bäsecke, J; Cervello, M; Nicoletti, F; Libra, M; Martelli, Am; Mccubrey, Ja | |
| Altered gene expression profiles in liver cancer cells upon sorafenib treatment. | 1-gen-2010 | Cervello, M; Bachvarov, D; Cusimano, A; Azzolina, A; Lampiasi, N; Abbaleo, S; Sardina, F; Giannitrapani, L; Mccubrey, Ja; Montalto, G | |
| Altered gene expression profiles in liver cancer cells upon sorafenib treatment. | 1-gen-2011 | Cervello, M; Cusimano, A; Bachvarov, D; Azzolina, A; Mccubrey, Ja; Montalto, G; Lampiasi, N | |
| Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells. | 1-gen-2013 | A Cusimano; N D'Alessandro; JA McCubrey; G Montalto; M Cervello | |
| Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression | 1-gen-2004 | Notarbartolo M; Poma P; Di Peri D; Cervello M; DAlessandro N | |
| Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression. | 1-gen-2004 | Notarbartolo, M; Poma, P; Di Peri, D; Cervello, M; Dalessandro, N | |
| Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression | 1-gen-2005 | Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; DAlessandro N | |
| Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. | 1-gen-2009 | Lampiasi, N; Azzolina, A; D'Alessandro, N; Umezawa, K; Mccubrey, Ja; Montalto, G; Cervello, M | |
| Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production | 1-gen-2005 | Notarbartolo M; Labbozzetta M; Poma P; Alaimo A; Maurici A; Cervello M; DAlessandro N | |
| Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production. | 1-gen-2005 | Notarbartolo, M; Labbozzetta, M; Poma, P; Alaimo, A; Maurici, A; Cervello, M; Dalessandro, N | |
| Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production | 1-gen-2006 | Poma, P; Notarbartolo, M; Labbozzetta, M; Sanguedolce, R; Alaimo, A; Carina, V; Maurici, A; Cusimano, A; Cervello, M; D'Alessandro, N | |
| Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production | 1-gen-2006 | Poma, P; Notarbartolo, M; Labbozzetta, M; Sanguedolce, R; Alaimo, A; Carina, V; Maurici, A; Cusimano, ; Cervello, M; D'Alessandro, N | |
| Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells | 1-gen-2005 | Cusimano A; Foderà D; Lampiasi N; Azzolina A; Montalto G; Cervello M |